Catalyst creates new opportunities
Degussa have discovered a catalyst that improves the efficiency of reductive carbonylation reactions and will provide greater access to new active pharmaceutical ingredients (APIs).
Degussa have discovered a catalyst that improves the efficiency of reductive carbonylation reactions and will provide greater access to new active pharmaceutical ingredients (APIs).
Increasing knowledge about how to manage the risks of gene therapy is set to usher in a new era in disease therapies, with the prospect of developing treatments in treating rare, inherited, or life-threatening diseases very real.
Sun Microsystems have strengthened the fight against drug counterfeiting by launching a unique RFID software package tailored to the specific needs of the pharmaceutical industry.
Researchers have identified two proteins involved in the process that controls plant growth, which may help explain why human cells reject chemotherapy drugs and could form a basis for new oncology drugs.
A US district court has denied a motion by Bio-Rad Laboratories to enforce an alleged settlement agreement with Applied Biosystems meaning the life science research product provider cannot continue selling its thermal cycler products.
Researchers have shown how protein synthesis is targeted to certain regions of a cell, a process crucial for the cellular motility, which could form a basis for producing a drug that could force tumour cells to express this protein, preventing cancers...